Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Early Phase 1
Terminated
- Conditions
- Myelodysplastic SyndromeAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation RecipientNon-Hodgkin LymphomaPlasma Cell MyelomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaMinimal Residual DiseaseRecurrent Diffuse Large B-Cell LymphomaRecurrent Hematologic Malignancy
- Interventions
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 2
- Registration Number
- NCT03272633
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer
Phase 2
Recruiting
- Conditions
- Stage II Gastric Cancer AJCC v7Stage IIIA Gastric Cancer AJCC v7Stage IIIB Gastric Cancer AJCC v7Epstein-Barr Virus PositiveGastric AdenocarcinomaMismatch Repair Protein DeficiencyStage IIA Gastric Cancer AJCC v7Stage IB Gastric Cancer AJCC v7Stage IIB Gastric Cancer AJCC v7Stage III Gastric Cancer AJCC v7
- Interventions
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 40
- Registration Number
- NCT03257163
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
Quality of Life Outcomes in Spinal Cord Stimulation
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 6
- Registration Number
- NCT03249922
- Locations
- 🇺🇸
Neurologic Institute of New Jersey, Newark, New Jersey, United States
Assuring Patient-centered Literacy Promotion for Underserved Children Study
- First Posted Date
- 2017-08-08
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 160
- Registration Number
- NCT03242850
- Locations
- 🇺🇸
Eric B. Chandler Health Center, New Brunswick, New Jersey, United States
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-08-04
- Last Posted Date
- 2020-07-01
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 335
- Registration Number
- NCT03239665
- Locations
- 🇺🇸
Rutgers University, Piscataway, New Jersey, United States
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 150
- Registration Number
- NCT03234478
- Locations
- 🇺🇸
Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Remote Ischemic Conditioning in Abdominal Surgery
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 100
- Registration Number
- NCT03234543
- Locations
- 🇺🇸
University Hospital, Newark, New Jersey, United States
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-28
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 535
- Registration Number
- NCT03233555
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 14
- Registration Number
- NCT03229278
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-07-24
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 30
- Registration Number
- NCT03228147
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
© Copyright 2024. All Rights Reserved by MedPath